We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > ChemRar Group

News List

ChemRar Group announces the Russian Avifavir® drug is effective against variants of COVID-19, including Delta and Omicron prnasia
December 28, 2021
ChemRar Group announces the Russian Avifavir® (INN: favipiravir) drug is effective against various variants of SARS-CoV-2 (coronavirus), including Delta and Omicron, as it affects the highly conservative...
Russia grants temporary approval for Avifavir to treat Covid-19 pharmaceutical-technology
June 02, 2020
The Ministry of Health of the Russian Federation has granted a temporary registration certificate to Covid-19 treatment, Avifavir, produced by the Russian Direct Investment Fund (RDIF) and ChemRar Group.